According to Myovant Sciences 's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2021 the company made an earning of -$0.23 B an increase over its 2020 earnings that were of -$0.24 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -$0.17 B | -28.2% |
2021 | -$0.23 B | -5.51% |
2020 | -$0.24 B | -19.76% |
2019 | -$0.3 B | 20.73% |
2018 | -$0.25 B | 112.55% |
2017 | -$0.12 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -31.74% | ๐บ๐ธ USA |